
Description
Tobin Scientific is a privately held, Massachusetts‑based firm established in 1960 that has evolved into a national provider of contract manufacturing‑style logistics for life sciences. With more than 40 years of experience supporting biopharma, research institutions, universities and government agencies, the company offers cGMP‑compliant warehousing, temperature‑controlled transport and laboratory relocation services. Operating a national fleet, multiple warehouses with over 365,000 sq ft of ambient and cGMP storage, and mobile cold‑room units, Tobin Scientific ensures continuity of custody and environmental control for critical research and pharmaceutical assets.
Key products and services
-
Ambient and cGMP Warehousing & Support: Secure ambient warehousing and cGMP‑compliant storage facilities, with real‑time environmental monitoring, temperature controls and ISO-certified processes.
-
Cold Chain Services: Temperature‑controlled transport and storage, including biorepository management, GMP‑bio support, refrigerated (2‑8 °C) cold rooms, mobile cold rooms and emergency response units.
-
Transport & Logistics: Laboratory relocation, distribution and fulfilment, principal investigator (PI) support, OEM inventory and lab‑related logistics services tailored for life sciences clients.
-
Lab Asset Management: Lab consumables, equipment and casework hosting, inventory management and precision installation with full chain‑of‑custody control.
-
OEM Support Services: White‑glove installation and support including specialized handling of high‑value and sensitive equipment for institutional and pharma clients.
Tobin Scientific has built its reputation on reliability, regulatory compliance and operational scale. Its fully certified teams, proprietary cold‑chain trailers and validated facilities support temperature‑sensitive life‑science workflows across the United States. By combining ambient and cold‑chain storage, precision logistics and laboratory relocation into a single service offering, Tobin Scientific enables research organisations and pharmaceutical companies to focus on innovation—confident in the integrity and custody of their critical materials.